Molecular characterization of carbapenem resistance mechanisms and phenotypic correlations in clinical Klebsiella pneumoniae isolates from Ningbo, China
ObjectiveThe purpose of this study is to understand the antimicrobial susceptibility and molecular distribution characteristics of carbapenem-resistant Klebsiella pneumoniae (CRKP) in the region, and to evaluate their correlation. Additionally, the study aims to investigate the transmission status o...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Microbiology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2025.1546805/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849727538334531584 |
|---|---|
| author | Xuedan Qiu Min Jiang Jianqiang Xu Qiaoping Wu Chenyao Lin Weiying Li Qingcao Li |
| author_facet | Xuedan Qiu Min Jiang Jianqiang Xu Qiaoping Wu Chenyao Lin Weiying Li Qingcao Li |
| author_sort | Xuedan Qiu |
| collection | DOAJ |
| description | ObjectiveThe purpose of this study is to understand the antimicrobial susceptibility and molecular distribution characteristics of carbapenem-resistant Klebsiella pneumoniae (CRKP) in the region, and to evaluate their correlation. Additionally, the study aims to investigate the transmission status of these strains.MethodsA total of 150 CRKP collected from January 2019 to December 2021 in the Ningbo region were included in this study. Antimicrobial susceptibility testing was performed using broth microdilution method following CLSI guidelines (CLSI, 2023). The tested agents included: (1) basic antimicrobials (tigecycline, polymyxin B, ceftazidime-avibactam); and (2) combination therapy candidates (ertapenem, imipenem, levofloxacin, piperacillin-tazobactam, ceftriaxone, cefepime, trimethoprim-sulfamethoxazole, fosfomycin, amikacin, aztreonam, chloramphenicol, amoxicillin-clavulanate, ceftazidime). Resistance genes were detected using polymerase chain reaction (PCR). Multi-locus sequence typing (MLST) was employed to analyze the molecular characteristics and evolutionary trends of the strains to determine their clonal relationships.ResultsThe 150 strains of CRKP exhibit high resistance rates to various conventional drugs; The sensitivity rates to tigecycline, polymyxin B, and ceftazidime-avibactam were 98.7, 98.0, and 68%, respectively; Conversely, the sensitivity rates to fosfomycin, amikacin, and chloramphenicol were 72.0, 40.0, and 16.7%, respectively; The main proportions of carbapemen genes producing in CRKP are as follows: KPC-2 (61.3%), NDM-5 (14.7%), IMP-4 (8.0%), OXA-232 (6.0%), and OXA-181 (1.3%); The main proportions of β-lactamase resistance genes are as follows: CTX-M-1 (13.33%), CTX-M-3 (25.33%), CTX-M-9 (17.33%), CTX-M-14 (34.67%), SHV-1 (26.66%), SHV-11 (66.66%), SHV-12 (18.66%), and SHV-28 (10.00%); CRKP carrying class A, B, and D carbapenemases had a sensitivity rate greater than 96% for tigecycline and polymyxin B, while their sensitivities to ceftazidime-avibactam, aztreonam, and amikacin varied significantly (p < 0.01). Analysis of the MLST results for CRKP revealed that ST11 strains were predominant in the region. There was a significant difference in the resistance genes carried by ST11 strains compared to non-ST11 strains. While different healthcare institutions exhibited variations in ST types, the strains generally showed high homogeneity.ConclusionIn the region, CRKP showed high sensitivity to tigecycline, polymyxin B, ceftazidime-avibactam, fosfomycin, amikacin, and chloramphenicol. The main carbapenemase genes identified were KPC-2 and NDM-5. The inhibitory effects of ceftazidime-avibactam, aztreonam, and amikacin varied for CRKP carrying different enzyme types. ST11 strains were predominant in the region. There was a significant difference in the resistance genes carried by ST11 strains compared to non-ST11 strains. Clonal dissemination was observed both within the same healthcare institution and between different institutions. |
| format | Article |
| id | doaj-art-9f47a35b0e1343e8bbbd276293ae3e45 |
| institution | DOAJ |
| issn | 1664-302X |
| language | English |
| publishDate | 2025-05-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Microbiology |
| spelling | doaj-art-9f47a35b0e1343e8bbbd276293ae3e452025-08-20T03:09:48ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2025-05-011610.3389/fmicb.2025.15468051546805Molecular characterization of carbapenem resistance mechanisms and phenotypic correlations in clinical Klebsiella pneumoniae isolates from Ningbo, ChinaXuedan Qiu0Min Jiang1Jianqiang Xu2Qiaoping Wu3Chenyao Lin4Weiying Li5Qingcao Li6Department of Clinical Laboratory, The Affiliated Li Huili Hospital of Ningbo University, Ningbo, ChinaDepartment of Clinical Laboratory, The Affiliated Li Huili Hospital of Ningbo University, Ningbo, ChinaDepartment of Clinical Laboratory, The Affiliated Li Huili Hospital of Ningbo University, Ningbo, ChinaDepartment of Clinical Laboratory, The Affiliated Li Huili Hospital of Ningbo University, Ningbo, ChinaDepartment of Clinical Laboratory, The Affiliated Li Huili Hospital of Ningbo University, Ningbo, ChinaDepartment of Clinical Laboratory, Langxia Street Health Service Center, Ningbo, ChinaDepartment of Clinical Laboratory, The Affiliated Li Huili Hospital of Ningbo University, Ningbo, ChinaObjectiveThe purpose of this study is to understand the antimicrobial susceptibility and molecular distribution characteristics of carbapenem-resistant Klebsiella pneumoniae (CRKP) in the region, and to evaluate their correlation. Additionally, the study aims to investigate the transmission status of these strains.MethodsA total of 150 CRKP collected from January 2019 to December 2021 in the Ningbo region were included in this study. Antimicrobial susceptibility testing was performed using broth microdilution method following CLSI guidelines (CLSI, 2023). The tested agents included: (1) basic antimicrobials (tigecycline, polymyxin B, ceftazidime-avibactam); and (2) combination therapy candidates (ertapenem, imipenem, levofloxacin, piperacillin-tazobactam, ceftriaxone, cefepime, trimethoprim-sulfamethoxazole, fosfomycin, amikacin, aztreonam, chloramphenicol, amoxicillin-clavulanate, ceftazidime). Resistance genes were detected using polymerase chain reaction (PCR). Multi-locus sequence typing (MLST) was employed to analyze the molecular characteristics and evolutionary trends of the strains to determine their clonal relationships.ResultsThe 150 strains of CRKP exhibit high resistance rates to various conventional drugs; The sensitivity rates to tigecycline, polymyxin B, and ceftazidime-avibactam were 98.7, 98.0, and 68%, respectively; Conversely, the sensitivity rates to fosfomycin, amikacin, and chloramphenicol were 72.0, 40.0, and 16.7%, respectively; The main proportions of carbapemen genes producing in CRKP are as follows: KPC-2 (61.3%), NDM-5 (14.7%), IMP-4 (8.0%), OXA-232 (6.0%), and OXA-181 (1.3%); The main proportions of β-lactamase resistance genes are as follows: CTX-M-1 (13.33%), CTX-M-3 (25.33%), CTX-M-9 (17.33%), CTX-M-14 (34.67%), SHV-1 (26.66%), SHV-11 (66.66%), SHV-12 (18.66%), and SHV-28 (10.00%); CRKP carrying class A, B, and D carbapenemases had a sensitivity rate greater than 96% for tigecycline and polymyxin B, while their sensitivities to ceftazidime-avibactam, aztreonam, and amikacin varied significantly (p < 0.01). Analysis of the MLST results for CRKP revealed that ST11 strains were predominant in the region. There was a significant difference in the resistance genes carried by ST11 strains compared to non-ST11 strains. While different healthcare institutions exhibited variations in ST types, the strains generally showed high homogeneity.ConclusionIn the region, CRKP showed high sensitivity to tigecycline, polymyxin B, ceftazidime-avibactam, fosfomycin, amikacin, and chloramphenicol. The main carbapenemase genes identified were KPC-2 and NDM-5. The inhibitory effects of ceftazidime-avibactam, aztreonam, and amikacin varied for CRKP carrying different enzyme types. ST11 strains were predominant in the region. There was a significant difference in the resistance genes carried by ST11 strains compared to non-ST11 strains. Clonal dissemination was observed both within the same healthcare institution and between different institutions.https://www.frontiersin.org/articles/10.3389/fmicb.2025.1546805/fullKlebsiella pneumoniaecarbapenem-resistantantibacterial susceptibilityresistance genesMLST |
| spellingShingle | Xuedan Qiu Min Jiang Jianqiang Xu Qiaoping Wu Chenyao Lin Weiying Li Qingcao Li Molecular characterization of carbapenem resistance mechanisms and phenotypic correlations in clinical Klebsiella pneumoniae isolates from Ningbo, China Frontiers in Microbiology Klebsiella pneumoniae carbapenem-resistant antibacterial susceptibility resistance genes MLST |
| title | Molecular characterization of carbapenem resistance mechanisms and phenotypic correlations in clinical Klebsiella pneumoniae isolates from Ningbo, China |
| title_full | Molecular characterization of carbapenem resistance mechanisms and phenotypic correlations in clinical Klebsiella pneumoniae isolates from Ningbo, China |
| title_fullStr | Molecular characterization of carbapenem resistance mechanisms and phenotypic correlations in clinical Klebsiella pneumoniae isolates from Ningbo, China |
| title_full_unstemmed | Molecular characterization of carbapenem resistance mechanisms and phenotypic correlations in clinical Klebsiella pneumoniae isolates from Ningbo, China |
| title_short | Molecular characterization of carbapenem resistance mechanisms and phenotypic correlations in clinical Klebsiella pneumoniae isolates from Ningbo, China |
| title_sort | molecular characterization of carbapenem resistance mechanisms and phenotypic correlations in clinical klebsiella pneumoniae isolates from ningbo china |
| topic | Klebsiella pneumoniae carbapenem-resistant antibacterial susceptibility resistance genes MLST |
| url | https://www.frontiersin.org/articles/10.3389/fmicb.2025.1546805/full |
| work_keys_str_mv | AT xuedanqiu molecularcharacterizationofcarbapenemresistancemechanismsandphenotypiccorrelationsinclinicalklebsiellapneumoniaeisolatesfromningbochina AT minjiang molecularcharacterizationofcarbapenemresistancemechanismsandphenotypiccorrelationsinclinicalklebsiellapneumoniaeisolatesfromningbochina AT jianqiangxu molecularcharacterizationofcarbapenemresistancemechanismsandphenotypiccorrelationsinclinicalklebsiellapneumoniaeisolatesfromningbochina AT qiaopingwu molecularcharacterizationofcarbapenemresistancemechanismsandphenotypiccorrelationsinclinicalklebsiellapneumoniaeisolatesfromningbochina AT chenyaolin molecularcharacterizationofcarbapenemresistancemechanismsandphenotypiccorrelationsinclinicalklebsiellapneumoniaeisolatesfromningbochina AT weiyingli molecularcharacterizationofcarbapenemresistancemechanismsandphenotypiccorrelationsinclinicalklebsiellapneumoniaeisolatesfromningbochina AT qingcaoli molecularcharacterizationofcarbapenemresistancemechanismsandphenotypiccorrelationsinclinicalklebsiellapneumoniaeisolatesfromningbochina |